CTI BioPharma Common Stock

CTI BioPharma (CTIC) currently reports a common stock of $130K as of March 2023. That compares with $100M in the prior-year period — down 99.9% year over year. Use the charts on this page to explore CTI BioPharma's common stock history and peer comparisons.

CTI BioPharma's common stock decreased from $100M to $130K — a 99.9% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CTI BioPharma reported $130K in common stock as of March 2023. That compares with $100M in the prior-year period — down 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $130K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CTI BioPharma, and consider following CTIC for alerts when major investors trade the stock.

CTI BioPharma is classified in the Healthcare sector. On common stock, it currently shows $130K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTIC with unrelated industries.